ROY, Pushpita; BANIK, Dipaloke; CHOWDHURY, Forhad; BAKAR SIDDIQUE, Md Abu. Magnitude of Survival Benefit Associated With Tyrosine Kinase Inhibitors in Advanced Thyroid Carcinoma: A Systematic Review and Meta-Analysis Incorporating Updated Long-Term Evidence From SELECT (Lenvatinib) and COSMIC-311 (Cabozantinib) Trials. World Journal of Oncology, [S. l.], v. 17, n. 5, p. 599–613, 2026. DOI: 10.14740/wjon2842. Disponível em: https://wjon.elmerpub.com/wjon/article/view/2842.. Acesso em: 5 sep. 2026.